Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−38.26 MXN
−3.78 B MXN
12.70 B MXN
65.18 M
About Tandem Diabetes Care, Inc.
Sector
Industry
CEO
John F. Sheridan
Website
Headquarters
San Diego
Founded
2006
FIGI
BBG0166TWDL8
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
TNDM5680851
Tandem Diabetes Care, Inc. 1.5% 01-MAY-2025Yield to maturity
5.44%
Maturity date
May 1, 2025
Explore more bonds
Frequently Asked Questions
The current price of TNDM is 745.00 MXN — it has increased by 0.45% in the past 24 hours. Watch TANDEM DIABETES CARE INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange TANDEM DIABETES CARE INC stocks are traded under the ticker TNDM.
TNDM stock has risen by 0.45% compared to the previous week, the month change is a 0.45% rise, over the last year TANDEM DIABETES CARE INC has showed a −7.70% decrease.
We've gathered analysts' opinions on TANDEM DIABETES CARE INC future price: according to them, TNDM price has a max estimate of 1,544.77 MXN and a min estimate of 370.74 MXN. Watch TNDM chart and read a more detailed TANDEM DIABETES CARE INC stock forecast: see what analysts think of TANDEM DIABETES CARE INC and suggest that you do with its stocks.
TNDM reached its all-time high on May 4, 2022 with the price of 2,366.04 MXN, and its all-time low was 666.88 MXN and was reached on Aug 1, 2024. View more price dynamics on TNDM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TNDM stock is 2.15% volatile and has beta coefficient of 1.33. Track TANDEM DIABETES CARE INC stock price on the chart and check out the list of the most volatile stocks — is TANDEM DIABETES CARE INC there?
Today TANDEM DIABETES CARE INC has the market capitalization of 49.42 B, it has decreased by −1.04% over the last week.
Yes, you can track TANDEM DIABETES CARE INC financials in yearly and quarterly reports right on TradingView.
TANDEM DIABETES CARE INC is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
TNDM earnings for the last quarter are −6.90 MXN per share, whereas the estimation was −8.02 MXN resulting in a 14.06% surprise. The estimated earnings for the next quarter are −4.43 MXN per share. See more details about TANDEM DIABETES CARE INC earnings.
TANDEM DIABETES CARE INC revenue for the last quarter amounts to 4.79 B MXN, despite the estimated figure of 4.42 B MXN. In the next quarter, revenue is expected to reach 5.24 B MXN.
TNDM net income for the last quarter is −458.13 M MXN, while the quarter before that showed −565.19 M MXN of net income which accounts for 18.94% change. Track more TANDEM DIABETES CARE INC financial stats to get the full picture.
No, TNDM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 8, 2025, the company has 2.40 K employees. See our rating of the largest employees — is TANDEM DIABETES CARE INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TANDEM DIABETES CARE INC EBITDA is −2.31 B MXN, and current EBITDA margin is −18.56%. See more stats in TANDEM DIABETES CARE INC financial statements.
Like other stocks, TNDM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TANDEM DIABETES CARE INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TANDEM DIABETES CARE INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TANDEM DIABETES CARE INC stock shows the strong sell signal. See more of TANDEM DIABETES CARE INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.